Descrizione
Additional barrier function or inflammatory pathway data from the study of butyrate protection against AIEC-mediated epithelial disruption. The findings support short-chain fatty acid supplementation as a potential strategy in IBD management.
Figure 5
ChartSource Paper
Butyrate reduces adherent-invasive E. coli-evoked disruption of epithelial mitochondrial morphology and barrier function: involvement of free fatty acid receptor 3.Cite This Figure
![Figure 5: Additional barrier function or inflammatory pathway data from the study of butyrate protection against AIEC-mediated epithelial disruption. The findings support short-chain fatty acid supplementation as a potential strategy in IBD management.]() > Source: Samira A Hamed et al. "Butyrate reduces adherent-invasive E. coli-evoked disruption of epithelial mitoc." *Gut microbes*, 2023. PMID: [38078655](https://pubmed.ncbi.nlm.nih.gov/38078655/)
<figure> <img src="" alt="Additional barrier function or inflammatory pathway data from the study of butyrate protection against AIEC-mediated epithelial disruption. The findings support short-chain fatty acid supplementation as a potential strategy in IBD management." /> <figcaption>Figure 5. Additional barrier function or inflammatory pathway data from the study of butyrate protection against AIEC-mediated epithelial disruption. The findings support short-chain fatty acid supplementation as a potential strategy in IBD management.<br> Source: Samira A Hamed et al. "Butyrate reduces adherent-invasive E. coli-evoked disruption of epithelial mitoc." <em>Gut microbes</em>, 2023. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/38078655/">38078655</a></figcaption> </figure>